Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure

BACKGROUND: Achieving target doses of angiotensin‐converting‐enzyme inhibitor/angiotensin‐receptor blockers (ACEi/ARB) and beta‐blockers in heart failure with reduced ejection fraction (HFrEF) is often underperformed. In BIOlogy Study to TAilored Treatment in chronic heart failure (BIOSTAT‐CHF) stud...

詳細記述

保存先:
書誌詳細
出版年:Clin Cardiol
主要な著者: Kobayashi, Masatake, Voors, Adriaan A., Ouwerkerk, Wouter, Duarte, Kevin, Girerd, Nicolas, Rossignol, Patrick, Metra, Marco, Lang, Chim C., Ng, Leong L., Filippatos, Gerasimos, Dickstein, Kenneth, van Veldhuisen, Dirk J., Zannad, Faiez, Ferreira, João Pedro
フォーマット: Artigo
言語:Inglês
出版事項: Wiley Periodicals, Inc. 2021
主題:
Clinical Investigations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8207977/
https://ncbi.nlm.nih.gov/pubmed/33960439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23576
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料